{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T01:39:12Z","timestamp":1775957952511,"version":"3.50.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T00:00:00Z","timestamp":1236297600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0004724","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T02:40:04Z","timestamp":1236307204000},"page":"e4724","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":824,"title":["Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update"],"prefix":"10.1371","volume":"4","author":[{"given":"Diane E.","family":"Bennett","sequence":"first","affiliation":[]},{"given":"Ricardo J.","family":"Camacho","sequence":"additional","affiliation":[]},{"given":"Dan","family":"Otelea","sequence":"additional","affiliation":[]},{"given":"Daniel R.","family":"Kuritzkes","sequence":"additional","affiliation":[]},{"given":"Herv\u00e9","family":"Fleury","sequence":"additional","affiliation":[]},{"given":"Mark","family":"Kiuchi","sequence":"additional","affiliation":[]},{"given":"Walid","family":"Heneine","sequence":"additional","affiliation":[]},{"given":"Rami","family":"Kantor","sequence":"additional","affiliation":[]},{"given":"Michael R.","family":"Jordan","sequence":"additional","affiliation":[]},{"given":"Jonathan M.","family":"Schapiro","sequence":"additional","affiliation":[]},{"given":"Anne-Mieke","family":"Vandamme","sequence":"additional","affiliation":[]},{"given":"Paul","family":"Sandstrom","sequence":"additional","affiliation":[]},{"given":"Charles A. B.","family":"Boucher","sequence":"additional","affiliation":[]},{"given":"David","family":"van de Vijver","sequence":"additional","affiliation":[]},{"given":"Soo-Yon","family":"Rhee","sequence":"additional","affiliation":[]},{"given":"Tommy F.","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Deenan","family":"Pillay","sequence":"additional","affiliation":[]},{"given":"Robert W.","family":"Shafer","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2009,3,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/135965350400900514","article-title":"Current patterns in the epidemiology of primary HIV drug resistance in North America and Europe.","volume":"9","author":"D Pillay","year":"2004","journal-title":"Antivir Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QCO.0b013e3280109ff1","article-title":"The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world.","volume":"19","author":"DE Bennett","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/QCO.0b013e328013caff","article-title":"Epidemiology of antiretroviral drug resistance in drug-naive persons.","volume":"20","author":"AM Geretti","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"ref4","article-title":"World Health Organization recommendations for surveillance of transmitted HIV drug resistance in resource-limited countries where antiviral therapy is rapidly expanding.","author":"DE Bennett","year":"2007"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/QAI.0b013e318185725f","article-title":"The Impact of Different Definitions on the Estimated Rate of Transmitted HIV Drug Resistance in the United Kingdom.","volume":"49","author":"H Green","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/QAD.0b013e328011e691","article-title":"HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.","volume":"21","author":"RW Shafer","year":"2007","journal-title":"AIDS"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/135965350801302S13","article-title":"Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies.","volume":"2","author":"RW Shafer","year":"2008","journal-title":"Antivir Ther 13 Suppl"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1093\/bioinformatics\/bti569","article-title":"A statistical model for HIV-1 sequence classification using the subtype analyser (STAR).","volume":"21","author":"RE Myers","year":"2005","journal-title":"Bioinformatics"},{"key":"ref9","article-title":"In Vitro HIV-1 Resistance Selections with Combinations of Tenofovir and Emtricitabine or Abacavir and Lamivudine.","author":"NA Margot","year":"2006"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.aids.0000216387.60481.0e","article-title":"A rare HIV reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine.","volume":"20","author":"LL Ross","year":"2006","journal-title":"AIDS"},{"key":"ref11","first-page":"570","article-title":"Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan.","volume":"39","author":"JK Carr","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref12","article-title":"Antiviral activity of TMC125 against a panel of site-directed mutants encompassing mutations observed in vitro and in vivo [abstract 621].","author":"J Vingerhoets","year":"2004"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"12773","DOI":"10.1128\/JVI.79.20.12773-12782.2005","article-title":"TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments.","volume":"79","author":"J Vingerhoets","year":"2005","journal-title":"J Virol"},{"key":"ref14","first-page":"S34","article-title":"Impact of baseline mutations on the virological response to TMC125 in the phase III clinical trials DUET-1 and DUET-2 [abstract 32].","volume":"12","author":"J Vingerhoets","year":"2007","journal-title":"Antivir Ther"},{"key":"ref15","article-title":"Intellence. Package Insert.","author":"Tibotec","year":"2008"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1128\/JVI.00712-06","article-title":"Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir.","volume":"80","author":"JD Baxter","year":"2006","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/aid.2007.0173","article-title":"Resistance profile of darunavir: combined 24-week results from the POWER trials.","volume":"24","author":"S De Meyer","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/AAC.48.8.3122-3126.2004","article-title":"Distribution of human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing.","volume":"48","author":"SY Rhee","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/135965350801302S01","article-title":"Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia.","volume":"13","author":"WE Abegaz","year":"2008","journal-title":"Antivir Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/135965350801302S12","article-title":"Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006.","volume":"13","author":"G Maphalala","year":"2008","journal-title":"Antivir Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/135965350801302S09","article-title":"Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.","volume":"13","author":"V Pillay","year":"2008","journal-title":"Antivir Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/135965350801302S08","article-title":"Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania.","volume":"13","author":"GR Somi","year":"2008","journal-title":"Antivir Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/135965350801302S02","article-title":"Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi.","volume":"13","author":"K Kamoto","year":"2008","journal-title":"Antivir Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/aid.2007.0317","article-title":"Transmitted antiretroviral drug resistance surveillance among newly HIV type 1-diagnosed women attending an antenatal clinic in Entebbe, Uganda.","volume":"24","author":"N Ndembi","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/135965350801302S14","article-title":"HIV drug resistance transmission threshold survey in Bangkok, Thailand.","volume":"13","author":"S Sirivichayakul","year":"2008","journal-title":"Antivir Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/135965350801302S11","article-title":"HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam.","volume":"13","author":"HT Nguyen","year":"2008","journal-title":"Antivir Ther"},{"key":"ref27","article-title":"HIV Molecular Immunology 2006\/2007.","author":"B Korber","year":"2007"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/JVI.01547-06","article-title":"Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 protease.","volume":"81","author":"SM Mueller","year":"2007","journal-title":"J Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0004724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T07:56:30Z","timestamp":1684914990000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0004724"}},"subtitle":[],"editor":[{"given":"Douglas F.","family":"Nixon","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2009,3,6]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0004724","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,6]]}}}